The recent uptick in venture capital investments in the biotechnology sector and the increasing number of partnerships between large and smaller biotech firms should help drugmakers replenish their pipeline and come up with better products in the future. Data from a Moneytree report showed that the biotech industry secured more than $4 billion in venture capital investments last year, an 8% growth, making it the second-biggest investment sector for venture capitalists for the year.
Surge in VC funding, dealmaking will improve biotech drug pipeline
SmartBrief Job Listings for Health Care
Meridian Health Plan
|Assistant Vice President - Dental Director||
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management
|Director, Corporate Counsel - Regulatory Law||